The vision of T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments based on live bacteria.

T3 Pharmaceuticals was acquired by Boehringer Ingelheim on 22 November 2023.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2015
  • Number of employees in Switzerland
    10-19
Key business

You may also be interested in